Le systême français de bourses d'enseignement supérieur by Line CHAMSEDDINE

“…En 2008, 1.48 milliard d'euros ont été consacrés aux bourses, dont plus de 89 % aux bourses sur critêres sociaux devant bénéficier à  environ 487.000 étudiants (Marini, 2007). …”
Get full text

A Field Calibration Solution to Achieve High-Grade-Level Performance for Low-Cost Dual-Frequency GNSS Receiver and Antennas by Andreas Krietemeyer, Hans van der Marel, Nick van de Giesen, Marie-Claire ten Veldhuis

“…It does not require costly software, uses low-cost equipment (~500 Euros), requires limited specialist expertise, and takes complex processing steps into the cloud. …”
Get full text

“The way the Irish asylum system turns people into un-human is my problem”: An Interview with Ifedinma Dimbo by Sara Martín-Ruiz

“…In her short story, Dimbo tackles the issue of deprivation while in Direct Provision, with a walk through one of the most commercial streets in Dublin, Grafton Street, as seen through the eyes of a Nigerian female asylum seeker who has to live on the institutionally granted allowance of 19.10 euros per week. In 2012, the Irish Writers Exchange published Ifedinma Dimbo’s first novel, She Was Foolish? …”
Get full text

Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program by Bourbeau J, Granados D, Roze S, Durand-Zaleski I, Casan P, Köhler D, Tognella S, Viejo JL, Dal Negro RW, Kessler R

“…Costs were evaluated from a National Health Service perspective for France, Germany, and Spain, and in a pooled analysis, and were expressed in 2015 Euros (EUR). Quality of life was assessed using the 15D health-related quality-of-life instrument and mapped to utility scores. …”
Get full text

Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study by Finocchietti M, Marino ML, Rosa AC, Bellini A, Masiero L, Cardillo M, Massari M, Spila Alegiani S, Pierobon S, Ferroni E, Zanforlini M, Leoni O, Ledda S, Garau D, Davoli M, Addis A, Belleudi V

“…Choosing generic immunosuppressants during maintenance could result in yearly savings of around 2000 euros per person for each therapy ingredient.Conclusion: The study shows an increasing proportion of patients using generic immunosuppressive drugs over time suggesting a growing acceptance of generics within the transplant community and reveals comparable risk-benefit profiles between the generic and branded formulations of TAC, CsA, and MYC. …”
Get full text

Surviving and Coping with the Pandemic by Matiur Rahman

“…Both communities live hand-to-mouth and earn 100–500 BDT (1–5 euros) per day. During the lockdown period, no one was allowed to go outside and the earnings of many decreased to less than 50 BDT. …”
Get full text

Análisis de costes del programa integrado de tratamiento renal sustitutivo en la provincia de Toledo (2012-2013) by José L. Conde Olasagasti, José Eugenio Garcia Diaz, Pilar Carrasco Benitez, Miguel Ángel Mareque Ruiz, María Pilar Parras Partido, Inmaculada Moreno Alia, Laura Jimenez Lopez, Juan José Cia Lecumberri, Pilar Araque, María Luisa Fernandez

“…Resultados: a) Costes agregados: el coste anual fue de 15,84 (2012) y de 15,77 millones de euros (2013). Los procedimientos de diálisis representan el 40,2% y la atención hospitalaria más el consumo de fármacos, el 41,5%. …”
Get full text

Public health impact and return on investment of Belgium’s pediatric immunization program by Justin Carrico, Claire E. Mellott, Sandra E. Talbird, André Bento-Abreu, Barbara Merckx, Jessica Vandenhaute, Damia Benchabane, Nicolas Dauby, Nicolas Dauby, Nicolas Dauby, Olivier Ethgen, Olivier Ethgen, Philippe Lepage, Jeroen Luyten, Marc Raes, Steven Simoens, Marc Van Ranst, Amanda Eiden, Mawuli K. Nyaku, Goran Bencina

“…The model estimated discounted cases averted, disease-related deaths averted, life-years gained, quality-adjusted life-years gained, costs (2020 euros), and an overall benefit–cost ratio. Scenario analyses considered alternate assumptions for key model inputs.ResultsAcross all 11 pathogens, we estimated that the PIP prevented 226,000 cases of infections and 200 deaths, as well as the loss of 7,000 life-years and 8,000 quality-adjusted life-years over the lifetime of a birth cohort of 118,000 children. …”
Get full text

Evaluating Primary Care Plus interventions in the Netherlands: discussion of methods and results regarding the Quadruple Aim by Dirk Ruwaard, Tessa Quanjel, Esther van den Bogaart, Daan Westra, Niels Hameleers, Marielle Kroese

“…In the Netherlands for example, the expenditures on medical specialist care increased with more than 55% during the past decade to more than 27 billion euros in 2016. Therefore, redesigning healthcare delivery models is high on the Dutch political agenda. …”
Get full text

Determinants associated with uncontrolled asthma in Portugal: A national population-based study by C. Camarinha, M. Fernandes, V. Alarc.úo, J. Franco, M.E. Mana.ºas, C. B.írbara, P.J. Nicola

“…Factors significantly associated with poor asthma control scores were: age (OR 1.02 per year of age; 95% CI: 1.01.Çô1.03), female sex (OR 1.87; 95% CI: 1.15.Çô3.04), educational level (OR 0.5; 95% CI: 0.28.Çô0.89 at high school level or over), occupation (OR 4.92; 95% CI: 2.12.Çô11.42 if looking for a first job or unemployed) (OR 2.51; 95% CI: 1.35.Çô4.65 if being retired), income (OR 0.23; 95% CI: 0.07.Çô0.72 if >619 euros), BMI (OR 1.09 per BMI unit; 95% CI: 1.03.Çô1.14), having rhinitis symptoms (OR 4.40; 95% CI: 2.56.Çô7.58) and using inhaled corticosteroids (OR 0.44; 95%CI: 0.24.Çô0.82 if used in the past or never used).Looking for a first job or being unemployed, BMI and having rhinitis symptoms remained significant after multivariate adjustments. …”
Get full text

Impact of synthetic space-borne NO₂ observations from the Sentinel-4 and Sentinel-5P missions on tropospheric NO₂ analyses by R. Timmermans, A. Segers, L. Curier, L. Curier, R. Abida, J.-L. Attié, J.-L. Attié, L. El Amraoui, H. Eskes, J. de Haan, J. Kujanpää, W. Lahoz, A. Oude Nijhuis, A. Oude Nijhuis, S. Quesada-Ruiz, P. Ricaud, P. Veefkind, M. Schaap, M. Schaap

“…We assimilate the simulated observations into a chemistry transport model (LOTOS-EUROS) independent of the NR to evaluate their impact on modelled <span class="inline-formula">NO₂</span> tropospheric columns and surface concentrations. …”
Get full text

Effectiveness of the Advanced Practice Nursing interventions in the patient with heart failure: A systematic review by Javier Ordóñez‐Piedra, Jose Antonio Ponce‐Blandón, Jose Miguel Robles‐Romero, Juan Gómez‐Salgado, Nerea Jiménez‐Picón, Macarena Romero‐Martín

“…Regarding the third question, APN was cost‐effective in this type of patient as the cost reduction was eventually calculated in 1.9 million euros. Regarding the last question, quality of life of patients who have been cared for by an APN had notoriously improved, although one of the papers concluded that no significant differences were found. …”
Get full text

Szarvasi-1 and Its Potential to Become a Substitute for Maize Which Is Grown for the Purposes of Biogas Plants in the Czech Republic by Jaroslav Bernas, Jan Moudrý, Marek Kopecký, Petr Konvalina, Zdeněk Štěrba

“…The research findings show that Szarvasi-1 produces 5.7&#8315;6.7 Euros (EUR) per Gigajoule (GJ) of energy, depending on the growing technology used. …”
Get full text

To new heights by flying low: comparison of aircraft vertical NO₂ profiles to model simulations and implications for TROPOMI NO₂ retrievals by T. C. V. W. Riess, K. F. Boersma, K. F. Boersma, W. Van Roy, J. de Laat, E. Dammers, J. van Vliet

“…The higher horizontal resolution in the regional CAMS (Copernicus Atmosphere Monitoring Service) ensemble mean and the LOTOS-EUROS (Long Term Ozone Simulation European Operational Smog) model improves the surface level pollution estimates. …”
Get full text

Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study by Cordero A, Dalmau González-Gallarza R, Masana L, Fuster V, Castellano JM, Ruiz Olivar JE, Zsolt I, Sicras-Mainar A, González Juanatey JR

“…Incidence of cardiovascular events, health-care resources utilization and healthcare and non-healthcare costs (2020 Euros) were compared. Incremental cost-effectiveness ratios per cardiovascular event avoided were estimated.Results: After PSM, 1614 patients were recruited in each study cohort. …”
Get full text

QUINZE ANOS DE AVALIAÇÃO ECONÓMICA DE MEDICAMENTOS EM PORTUGAL: UMA REVISÃO by Mónica Inês, Miguel Gouveia, Céu Mateus, Luís Silva Miguel, António Pinto, Carlos Gouveia Pinto

“…Grande parte dos estudos (36 por cento) reportou resultados de dominância versus comparação e apenas 14 por cento dos estudos reporta rácios superiores a 30 mil euros, o que pode indiciar algum viés de seleção de publicações de estudos com resultados mais positivos. …”
Get full text

IMPLANTAÇÃO DA COMPANHIA SIDERÚRGICA DO ATLÂNTICO NA BAÍA DE SEPETIBA-RJ by Patrícia Santiago Pato

“…A Companhia Siderúrgica do Atlântico (CSA) é  uma parceria da Companhia Vale do Rio Doce com a alemã Thyssenkrupp, cujo investimento é da ordem de € 5,2 bilhões de euros. A produção prevista é de cinco milhões de toneladas de placas de aço por ano, resultando no aumento de 40% das exportações brasileiras no setor siderúrgico. …”
Get full text

Servicios ambientales del bosque: ensayo en una cuenca atlántica europea con base en la experiencia de Centroamérica by Oreina Orrantia Albizu, M. Mercedes Ortega Hidalgo, Olman Quirós Madrigal, Javier Loidi Arregui

“…Luego, se formuló un método de compensación económica (PSA = euros), que permite la conservación de las áreas naturales de calidad que son propiedad privada. …”
Get full text

Refugee children and adolescents in Greece: two case reports by Ignatia Farmakopoulou, Kalliopi Triantafyllou, Gerasimos Kolaitis

“…His treatment costed thousands of euros, and the medical and nursing staff did their best to help him. …”
Get full text

Consequências clínicas e económicas da utilização de dabigatrano e de rivaroxabano em doentes com fibrilhação auricular não valvular by Luís Silva Miguel, Jorge Ferreira

“…The reduction in events is reflected in longer survival (8.41 vs. 8.26 years) and more quality‐adjusted life years (5.87 vs. 5.74), while the lower daily treatment cost and the reduction in event‐related costs lead to a saving of 367 euros per patient from a societal perspective. Conclusions: The results show that dabigatran is a dominant alternative, i.e., it produces better clinical results at a lower cost. …”
Get full text